4-phenylbutyric acid has been researched along with mechlorethamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| GALTON, DA; ISRAELS, LG; NABARRO, JD; TILL, M | 1 |
| PERISCO, L; PIACENTINI, G | 1 |
1 review(s) available for 4-phenylbutyric acid and mechlorethamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for 4-phenylbutyric acid and mechlorethamine
| Article | Year |
|---|---|
Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
Topics: Chlorambucil; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; Phenylbutyrates | 1955 |
[p-(Bis-2-chloroethylamino)-phenylbutyric acid (CB 1348) in oncological therapy].
Topics: Chlorambucil; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Phenylbutyrates | 1960 |